SCHEMBL21101774

SCHEMBL21101774

COc1ccc(OC(N)=O)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.59
CA1 P00915 2/20 0.59
CA2 P00918 2/20 0.59
CA7 P43166 2/20 0.59
CA9 Q16790 2/20 0.59
CA14 Q9ULX7 2/20 0.59
KMT2A Q03164 4/20 0.55
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 4/20 0.53
GAA P10253 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
TSHR P16473 1/20 0.52
CYP2C19 P33261 1/20 0.52
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
TPMT P51580 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14734821 0.89 CA12 (0.67) CA12CA1CA2CA7CA9
SCHEMBL28651236 0.88 MEN1 (0.47) CA12CA1CA2CA7CA9
SCHEMBL28945284 0.87 MEN1 (0.53) CA12CA1CA2CA7CA9
SCHEMBL28945286 0.87 TUBB4A (0.51) CA12CA1CA2CA7CA9
SCHEMBL14543278 0.87 KMT2A (0.50) CA12CA1CA2CA7CA9
SCHEMBL28663584 0.86 MAPK1 (0.56) KMT2AMEN1GAATSHRKDM4E
SCHEMBL28324863 0.85 MEN1 (0.48) CA12CA1CA2CA7CA9
SCHEMBL153056 0.84 CA12 (0.59) CA12CA1CA2CA7CA9
SCHEMBL27655956 0.84 CA12 (0.59) CA12CA1CA2CA7CA9
SCHEMBL28945282 0.83 KDM4E (0.58) KMT2AMEN1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113226377-A Antibody drug conjugates comprising an eltrinastine derivative 法马马有限公司 2021-08-06 CN disclosed
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 WO disclosed
CN-104039152-A Antibacterial compounds GLAXO GROUP LTD 2014-09-10 CN disclosed
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed